【レポートの概要（一部）】
Introduction 16
Wound Closure Devices Overview 16
Products under Development 18
Wound Closure Devices – Pipeline Products by Stage of Development 18
Wound Closure Devices – Pipeline Products by Segment 19
Wound Closure Devices – Pipeline Products by Territory 20
Wound Closure Devices – Pipeline Products by Regulatory Path 21
Wound Closure Devices – Pipeline Products by Estimated Approval Date 22
Wound Closure Devices – Ongoing Clinical Trials 23
Wound Closure Devices – Pipeline Products under Development by Companies 24
Wound Closure Devices Companies – Pipeline Products by Stage of Development 24
Wound Closure Devices – Pipeline Products by Stage of Development 27
Wound Closure Devices Companies and Product Overview 30
3-D Matrix Europe SAS Company Overview 30
3-D Matrix Europe SAS Pipeline Products & Ongoing Clinical Trials Overview 30
3-D Matrix, Ltd. Company Overview 31
3-D Matrix, Ltd. Pipeline Products & Ongoing Clinical Trials Overview 31
Advanced Medical Solutions Group plc Company Overview 33
Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview 33
Anika Therapeutics, Inc. Company Overview 37
Anika Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
Arch Therapeutics Inc. Company Overview 39
Arch Therapeutics Inc. Pipeline Products & Ongoing Clinical Trials Overview 39
Arsenal Medical, Inc. Company Overview 40
Arsenal Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
Baxter International Inc. Company Overview 41
Baxter International Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
Baxter International Inc. – Ongoing Clinical Trials Overview 43
Bergen Medical Products, Inc. Company Overview 45
Bergen Medical Products, Inc. Pipeline Products & Ongoing Clinical Trials Overview 45
Beth Israel Deaconess Medical Center, Inc. Company Overview 46
Beth Israel Deaconess Medical Center, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
Boston Scientific Corporation Company Overview 47
Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 47
Boston University Company Overview 49
Boston University Pipeline Products & Ongoing Clinical Trials Overview 49
C. R. Bard, Inc. Company Overview 50
C. R. Bard, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
Cellphire, Inc. Company Overview 52
Cellphire, Inc. Pipeline Products & Ongoing Clinical Trials Overview 52
Clemson University Company Overview 54
Clemson University Pipeline Products & Ongoing Clinical Trials Overview 54
Cohera Medical, Inc. Company Overview 55
Cohera Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
Cook Medical Incorporated Company Overview 58
Cook Medical Incorporated Pipeline Products & Ongoing Clinical Trials Overview 58
Cook Medical Incorporated – Ongoing Clinical Trials Overview 60
Covalon Technologies Ltd. Company Overview 63
Covalon Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 63
CryoLife, Inc. Company Overview 65
CryoLife, Inc. Pipeline Products & Ongoing Clinical Trials Overview 65
CryoLife, Inc. – Ongoing Clinical Trials Overview 67
Emory University Company Overview 69
Emory University Pipeline Products & Ongoing Clinical Trials Overview 69
Endomedix Incorporated Company Overview 70
Endomedix Incorporated Pipeline Products & Ongoing Clinical Trials Overview 70
Entegrion, Inc. Company Overview 72
Entegrion, Inc. Pipeline Products & Ongoing Clinical Trials Overview 72
Floralis S.A.S. Company Overview 73
Floralis S.A.S. Pipeline Products & Ongoing Clinical Trials Overview 73
Gamma Therapeutics, Inc. Company Overview 74
Gamma Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 74
Gecko Biomedical Company Overview 76
Gecko Biomedical Pipeline Products & Ongoing Clinical Trials Overview 76
Grifols, S.A. Company Overview 78
Grifols, S.A. Pipeline Products & Ongoing Clinical Trials Overview 78
Grifols, S.A. – Ongoing Clinical Trials Overview 80
Haemostatix Ltd Company Overview 83
Haemostatix Ltd Pipeline Products & Ongoing Clinical Trials Overview 83
Hemostasis, LLC Company Overview 85
Hemostasis, LLC Pipeline Products & Ongoing Clinical Trials Overview 85
HyperBranch Medical Technology, Inc. Company Overview 88
HyperBranch Medical Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 88
InVivo Therapeutics Corporation Company Overview 90
InVivo Therapeutics Corporation Pipeline Products & Ongoing Clinical Trials Overview 90
IonMed Ltd. Company Overview 91
IonMed Ltd. Pipeline Products & Ongoing Clinical Trials Overview 91
Johns Hopkins University Company Overview 92
Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 92
KeraNetics, LLC Company Overview 93
KeraNetics, LLC Pipeline Products & Ongoing Clinical Trials Overview 93
Kitotech Medical, Inc. Company Overview 94
Kitotech Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 94
Kuros Biosurgery AG Company Overview 96
Kuros Biosurgery AG Pipeline Products & Ongoing Clinical Trials Overview 96
Laser Tissue Welding, Inc. Company Overview 99
Laser Tissue Welding, Inc. Pipeline Products & Ongoing Clinical Trials Overview 99
LifeBond Ltd. Company Overview 100
LifeBond Ltd. Pipeline Products & Ongoing Clinical Trials Overview 100
Medical Adhesive Revolution GmbH Company Overview 103
Medical Adhesive Revolution GmbH Pipeline Products & Ongoing Clinical Trials Overview 103
Medisse BV Company Overview 105
Medisse BV Pipeline Products & Ongoing Clinical Trials Overview 105
Medtronic plc Company Overview 106
Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 106
OptMed, Inc. Company Overview 107
OptMed, Inc. Pipeline Products & Ongoing Clinical Trials Overview 107
Remedium Technologies Inc. Company Overview 108
Remedium Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 108
Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview 110
Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview 110
Rice University Company Overview 111
Rice University Pipeline Products & Ongoing Clinical Trials Overview 111
Samyang Biopharmaceuticals Corporation Company Overview 112
Samyang Biopharmaceuticals Corporation Pipeline Products & Ongoing Clinical Trials Overview 112
Sea Run Holdings Inc. Company Overview 115
Sea Run Holdings Inc. Pipeline Products & Ongoing Clinical Trials Overview 115
Sealantis Ltd. Company Overview 116
Sealantis Ltd. Pipeline Products & Ongoing Clinical Trials Overview 116
St Teresa Medical, Inc. Company Overview 119
St Teresa Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 119
Suneris Technologies, Inc. Company Overview 121
Suneris Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 121
Teijin Pharma Limited Company Overview 122
Teijin Pharma Limited Pipeline Products & Ongoing Clinical Trials Overview 122
The Medicines Company Company Overview 123
The Medicines Company Pipeline Products & Ongoing Clinical Trials Overview 123
University of Akron Company Overview 127
University of Akron Pipeline Products & Ongoing Clinical Trials Overview 127
VitaThreads, LLC Company Overview 128
VitaThreads, LLC Pipeline Products & Ongoing Clinical Trials Overview 128
Vivostat A/S Company Overview 129
Vivostat A/S Pipeline Products & Ongoing Clinical Trials Overview 129
Vivostat A/S – Ongoing Clinical Trials Overview 131
Wound Management Technologies, Inc. Company Overview 133
Wound Management Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 133
Xcede Technologies, Inc. Company Overview 134
Xcede Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 134
Wound Closure Devices- Recent Developments 135
Feb 17, 2015: Owens & Minor Reports 4th Quarter & Full-Year 2014 Financial Results 136
Feb 10, 2015: Premier awards specialty urology purchasing contract to Cook Medical 138
Feb 04, 2015: FDA approves first tissue adhesive for internal use 139
Feb 03, 2015: Vascular Solutions Reports Fourth Quarter Results 140
Jan 29, 2015: Bard Announces Fourth Quarter Results 142
Jan 28, 2015: Vascular Solutions to Purchase Additional Manufacturing Facility 143
Jan 20, 2015: United Health Products Reports Highly Significant Test Results for HemoStyp 145
Jan 15, 2015: United Health Products to Launch HemoStrip Adhesive Bandage to Retail Market 147
Dec 17, 2014: United Health Products Announces Australian Sales Update 150
Dec 17, 2014: Integra LifeSciences Launches Integra Meshed Dermal Regeneration Template 150
Dec 16, 2014: TissuePatchDural – New comparative clinical data published 151
Dec 11, 2014: United Health Products Announces Current Positive State of Events 152
Dec 02, 2014: Surgical Specialties Announces Leadership Team Additions 154
Dec 02, 2014: Vascular Solutions Completes Purchase of Principal Manufacturing Facility 155
Nov 24, 2014: Arch Therapeutics to Present at LD Micro Main Event on December 4th 2014 155
Nov 13, 2014: Cytomedix Announces Corporate Name Change to Nuo Therapeutics 157
Nov 13, 2014: Nuo Therapeutics Reports Third Quarter 2014 Financial Results 157
Nov 12, 2014: FDA Issues Warning Letter To Cadila Pharmaceuticals 159
Nov 10, 2014: Arch Therapeutics Will Present at Two Investor Conferences in November 159
Nov 10, 2014: Derma Sciences Reports Third Quarter Financial Results 160
Oct 27, 2014: Owens & Minor Reports Financial Results for 3rd Quarter 2014 163
Oct 27, 2014: Owens & Minor Announces Fourth Quarter 2014 Cash Dividend of $0.25 per Share 165
Oct 22, 2014: Bard Announces Third Quarter Results 165
Oct 21, 2014: United Health Products Receives Initial Medicom Order 165
Oct 21, 2014: Vascular Solutions Reports Third Quarter Results 165
Oct 16, 2014: Cytomedix Re-brands as Nuo Therapeutics 166
Oct 10, 2014: United Health Products Supplies Initial Stocking Order to AMD-Ritmed 167
Oct 09, 2014: Angiotech Appoints John Barr as CEO 167
Oct 08, 2014: Bard Declares Regular Quarterly Dividend 169
Sep 24, 2014: iTraumaCare Closes One Hundred Accounts in North America 171
Sep 24, 2014: iTClamp Hemorrhage Control System Honored as 2014 JEMS Hot Product 171
Sep 22, 2014: Aesculap Unveils Innovative 20 Points of Value Application 173
Sep 10, 2014: Tissuemed at SBNS Autumn 2014 Conference 178
Sep 10, 2014: Advanced Medical Solutions Interim Results for the six months ended 30 June 2014 178
Sep 08, 2014: Olympus Introduces QuickClip Pro Clips For GI Endoscopy 184
Aug 27, 2014: Covalon Announces Third Quarter Results 185
Aug 27, 2014: Theragenics Opens Manufacturing Plant in Costa Rica 186
Aug 26, 2014: Wallingford Ct. School District Partners with Z-Medica to Roll out the “SAFE” Program 186
Aug 14, 2014: Cytomedix Reports Second Quarter 2014 Financial Results 189
Aug 07, 2014: Derma Sciences Reports Second Quarter Financial Results 190
Jul 28, 2014: Owens & Minor Releases 2nd Quarter 2014 Financial Results 193
Jul 24, 2014: Bard Announces Second Quarter Results 195
Jul 22, 2014: Vascular Solutions Reports Second Quarter Results 196
Jul 21, 2014: US Patent Office Grants McCord Research Endothelial Cell Treatment Patent 197
Jul 15, 2014: Arch Therapeutics Selects BSI as Its European Union Notified Body 197
Jul 10, 2014: A start-up at NJIT develops bleeding-control gel for brain surgery 199
Jul 03, 2014: Vascular Solutions Issues Recall of Langston Dual Lumen Catheters 200
Jun 26, 2014: TissuePatch for leak prevention in Head and Neck Surgery – New Clinical Evidence 200
Jun 18, 2014: Tissuemed Patent Approval in India 200
May 15, 2014: Cohera Medical Files for CE Mark Approval for Sylys Surgical Sealant 205
May 15, 2014: Cytomedix Reports 2014 First Quarter Financial Results 205
May 12, 2014: Alliqua Reports First Quarter 2014 Financial Results 207
May 08, 2014: Derma Sciences Reports First Quarter Financial Results 208
May 02, 2014: Cook Medical Data Presented at Digestive Disease Week 209
Apr 24, 2014: Cook Medical Launches Instinct Endoscopic Hemoclip 210
Apr 22, 2014: Vascular Solutions Reports First Quarter Results 211
Apr 22, 2014: Bard Announces First Quarter Results 213
Apr 14, 2014: Alliqua Completes Private Placement Of Shares For US$15 Million 214
Mar 21, 2014: B. Braun Melsungen Announces 2013 Financial Results 221
Mar 12, 2014: Cohera Medical Awarded Key Patent on its Biodegradable Adhesive Technology 224
Mar 06, 2014: Sealantis Announces Successful Results of First Clinical Trial 224
Feb 26, 2014: Henry Ford Hospital Opens Pigmented Lesions Clinic 226
Appendix 227
Methodology 227
About GlobalData 230
Contact Us 230
Disclaimer 230
【レポート販売概要】
■ タイトル：創傷閉鎖デバイスのグローバル製品パイプライン動向2015■ 英文：Wound Closure Devices - Pipeline Review, 2015
■ 発行日：2015年3月20日
■ 調査会社：GlobalData
■ 商品コード：GDME0003EPD
■ 調査対象地域：グローバル
- 太陽光発電モジュール市場：規模、生産、価格、競争環境、主要地域分析（～2020）Solar PV Modules - Market Size, Annual Production, Average Price, Competitive Landscape and Key Country Analysis to 2020 Summary “Solar PV Modules - Market Size, Annual Production, Average Price, Competitive Landscape and Key Country Analysis to 2020” is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the global solar P …
- 世界の非接触型決済市場（技術進歩、予測、分析）The increasing requirement of the consumers to make online payments and payments via mobile phones is helping the society tomove toward a cashless society. Financial institutions are offering various types of payment services tending people to use more of cards and mobile phones for payments. The potential marketing strategies provided by various business segment and payments market is changing th …
- 動物飼料の世界市場2018-2022About Animal Feed Animal feed refers to food given to the animals and includes fodder or forages. The common animal feed variants include hay, straw, silage, compressed and pelleted feeds, oils and mixed rations, and sprouted grains and legumes. Also, food grains are the most important source of animal feed globally. Technavio’s analysts forecast the global animal feed market to grow at a CAGR of …
- 世界の3Dプリンティング市場（技術別、材料別、応用分野別、地域別分析）3D Printing Market (2013 - 2020) - By Technology (SLA, SLS, EBM, FDM, EBM, LOM, 3DP), Materials (Polymers, Metal), Application (Aerospace, Automotive, Consumer, Healthcare, Government & Defense) & Geography (Americas, Europe, APAC & ROW) 3D printing has been evolving as a technique to create 3D models and prototypes, in many industries, namely, automotive, aerospace, healthcare, and consumer produ …
- 機械状態モニタリングの世界市場予測：振動モニタリング、サーモグラフィー、潤滑油分析、腐食モニタリング、超音波放射、電流徴候解析（MCSA）The machine condition monitoring market is expected to be valued at USD 3.07 Billion by 2022, growing at a CAGR of 7.0% between 2016 and 2022. The growth of this market is propelled by the increasing use of wireless communication technology, growth in the HVAC systems market, rising trend of smart factory or Industry 4.0, and transition from preventive to predictive maintenance. Vibration monitori …
- 電気用鋼の世界市場予測（～2021）：トランス、モーター、インダクタMarketsandMarkets projects that the electrical steel market size will grow from USD 27.84 Billion in 2016 to USD 38.98 Billion by 2021, at an estimated CAGR of 7.0%. The electrical steel market is witnessing considerable growth due to advancements in technology and the high efficiency of electrical steel. The electrical steel market has immense opportunities due to the increasing demand from the p …
- コバルトの世界市場2015-2019About cobalt Cobalt is a chemical element obtained in combination with other elements in minerals such as skutterudite (a cobalt-nickel arsenide), carrollite (a copper-cobalt-(nickel) sulfide), and asbolane (a nickel-cobalt-manganese oxide). Cobalt is obtained from three main ore deposits: sediment-hosted stratiform copper deposits, magmatic nickel sulfide deposits, and nickel laterite deposits. I …
- ウレタンフォーム市場（世界動向と予測）Polyurethane foam is one of the most widely used polymeric foam in the world, finding applications in almost all the modern industries. These are made primarily by reacting diisocyanates (MDI or TDI) with polyols and other chemicals. Polyurethane occurs in mainly two forms; Polyurethane foams and Polyurethane non foams. These are classified on the basis of their commercially available forms as Fle …
- 北米の核医学/放射性医薬品市場：診断用（SPECT、PET）、治療用（ベータ放射体、アルファ放射体、小線源治療）The North American nuclear medicine market is expected to reach USD 2.98 Billion in 2020 from USD 1.97 Billion in 2015, growing at a CAGR of 8.6%. . Radiopharmaceuticals are drugs that contain radionuclide-emitting ionizing radiation, used in the nuclear imaging field to diagnose and treat various diseases. The North American nuclear medicine market is segmented on the basis of types, applications …
- 医療産業におけるフッ素ポリマーの世界市場2016-2020About Fluoropolymer Fluoropolymers are fluorocarbon-based polymers formed by strong bonding between carbon and fluorine, which makes them mechanically stable. They are high-performance plastics and are characterized by high resistance to acids, bases, and solvents. Fluoropolymers account for about 20% of all the fluorochemicals available in the market. Technavio’s analysts forecast the global fluo …
- オートバイ用エアバッグジャケットの世界市場2016-2020About Motorcycle Airbag Jacket Motorcycles are considered one of the most vulnerable modes of transport compared to other vehicles such as passenger cars, trucks, and buses. Most often these machines are built with high-performance engines, which result in a volatile weight-to-torque ratio. These factors make motorcycles the most vulnerable machines on the roads, adding greater risk to the riding …
- モーション制御の世界市場：構成要素（モータ、電気ドライブ、モーションコントローラ、ACモータ）、技術（GMC、CNC）、用途、地域別分析Motion control is a sub-field of automation, which controls the position and velocity of machines with the help of components such as motors, drives, sensors and motion controllers. Motion control is essential in robotics and Computerized Numerical Control (CNC) machine tools even though it is more complex when compared to its use in specialized machines such as General Motion Control (GMC). GMC i …
- 2G/3G/4G加入者、導入、スペクトラム、インフラ契約データベース（2G/3G/4G Subscriptions, Deployments, Spectrum Holdings and Infrastructure Contracts Database Q1’2012 ）With 49 large scale commercial deployments, LTE adoption has considerably gained momentum throughout the globe. Unique market and operator requirements have driven several early LTE launches. Driven by these early launches global LTE subscriptions reached 6.4 Million at the end of Q4’2011. Going forward, the LTE market is set to grow with a CAGR of 150 % over the next 5 years and will eventually r …
- 世界のファブレット（Phablet）市場動向（2012-2016）TechNavio's analysts forecast the Global Phablet market to grow at a CAGR of 26.9 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing adoption of phablets in the emerging markets. The Global Phablet market has also been witnessing an increased R&D spending. However, high production costs could pose a challenge to the growth of this market. …
- MRSA検査の世界市場2017-2021About MRSA testingMRSA has been a major cause of concern due to the long-term use of antibiotics, which is now deemed as unnecessary. The inappropriate use of antibiotics may contribute to the rise in drug-resistant bacteria because they do not destroy the bacteria completely. This has been one of the major factors influencing the use of MRSA testing in the medical industry. With this, there is fo …
